Invention Grant
US09174985B2 Salts of 7-(2,3-di-p-tolyl-7,8-dihydropyrido[2,3-b]pyrazin-5(6H)-yl)heptanoic acid as IP receptor agonists
有权
7-（2,3-二对甲苯基-7,8-二氢吡啶并[2,3-b]吡嗪-5（6H） - 基）庚酸盐作为IP受体激动剂
![Salts of 7-(2,3-di-p-tolyl-7,8-dihydropyrido[2,3-b]pyrazin-5(6H)-yl)heptanoic acid as IP receptor agonists](/docs/US/2015-11-03/US09174985B2/abs.jpg.600x600.jpg)
- Patent Title: Salts of 7-(2,3-di-p-tolyl-7,8-dihydropyrido[2,3-b]pyrazin-5(6H)-yl)heptanoic acid as IP receptor agonists
- Patent Title (中): 7-（2,3-二对甲苯基-7,8-二氢吡啶并[2,3-b]吡嗪-5（6H） - 基）庚酸盐作为IP受体激动剂
-
Application No.: US14371593Application Date: 2013-01-11
-
Publication No.: US09174985B2Publication Date: 2015-11-03
- Inventor: Catherine Leblanc , Stephen Carl McKeown , Anett Perlberg , Nicola Tufilli
- Applicant: Catherine Leblanc , Stephen Carl McKeown , Anett Perlberg , Nicola Tufilli
- Applicant Address: CH Basel
- Assignee: Novartis AG
- Current Assignee: Novartis AG
- Current Assignee Address: CH Basel
- Agent Shawn Britt
- International Application: PCT/IB2013/050283 WO 20130111
- International Announcement: WO2013/105066 WO 20130718
- Main IPC: C07D471/04
- IPC: C07D471/04
![Salts of 7-(2,3-di-p-tolyl-7,8-dihydropyrido[2,3-b]pyrazin-5(6H)-yl)heptanoic acid as IP receptor agonists](/abs-image/US/2015/11/03/US09174985B2/abs.jpg.150x150.jpg)
Abstract:
The invention relates to salts of (7-(2,3-di-p-tolyl-7,8-dihydropyrido[2,3-b]pyrazin-5(6H)-yl)heptanoic acid which are useful for treating diseases affected by the activation of the IP receptor, pharmaceutical compositions that contain the salts and processes for preparing the salts are also described.
Public/Granted literature
- US20150011555A1 Salts of an IP Receptor Agonist Public/Granted day:2015-01-08
Information query
